RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $272,771 | -10.4% | 252,566 | +7.1% | 0.00% | – |
| Q2 2023 | $304,342 | -16.8% | 235,924 | -14.8% | 0.00% | – |
| Q1 2023 | $365,695 | -87.6% | 277,042 | -85.9% | 0.00% | -100.0% |
| Q4 2022 | $2,949,449 | -47.1% | 1,966,299 | -58.4% | 0.00% | 0.0% |
| Q3 2022 | $5,573,000 | +22.3% | 4,721,848 | +17.2% | 0.00% | 0.0% |
| Q2 2022 | $4,555,000 | -62.5% | 4,030,384 | -0.9% | 0.00% | -50.0% |
| Q1 2022 | $12,155,000 | +208.3% | 4,065,211 | +173.3% | 0.00% | +100.0% |
| Q4 2021 | $3,942,000 | +336.5% | 1,487,521 | +498.1% | 0.00% | – |
| Q3 2021 | $903,000 | +10.0% | 248,715 | +31.4% | 0.00% | – |
| Q2 2021 | $821,000 | -93.0% | 189,300 | -94.4% | 0.00% | -100.0% |
| Q1 2021 | $11,648,000 | -48.7% | 3,405,786 | -47.5% | 0.00% | -50.0% |
| Q4 2020 | $22,689,000 | +49.0% | 6,482,407 | +2.1% | 0.01% | +50.0% |
| Q3 2020 | $15,232,000 | +80.9% | 6,346,257 | +38.0% | 0.00% | +33.3% |
| Q2 2020 | $8,418,000 | +37.6% | 4,599,800 | +17.3% | 0.00% | 0.0% |
| Q1 2020 | $6,119,000 | -23.1% | 3,922,527 | +5.5% | 0.00% | 0.0% |
| Q4 2019 | $7,954,000 | +12.7% | 3,716,770 | -1.5% | 0.00% | 0.0% |
| Q3 2019 | $7,056,000 | -40.7% | 3,773,201 | -17.2% | 0.00% | -40.0% |
| Q2 2019 | $11,897,000 | +12.3% | 4,558,281 | +10.6% | 0.01% | 0.0% |
| Q1 2019 | $10,595,000 | -33.9% | 4,122,579 | -40.9% | 0.01% | -44.4% |
| Q4 2018 | $16,039,000 | -10.9% | 6,973,302 | +24.3% | 0.01% | +12.5% |
| Q3 2018 | $18,006,000 | +2.5% | 5,609,356 | -9.6% | 0.01% | -11.1% |
| Q2 2018 | $17,559,000 | +53.6% | 6,204,504 | +92.1% | 0.01% | +50.0% |
| Q1 2018 | $11,434,000 | -27.9% | 3,229,856 | -21.0% | 0.01% | -40.0% |
| Q4 2017 | $15,866,000 | +2871.2% | 4,089,142 | +1845.0% | 0.01% | – |
| Q3 2017 | $534,000 | +43.5% | 210,235 | +54.5% | 0.00% | – |
| Q2 2017 | $372,000 | -33.9% | 136,072 | -20.0% | 0.00% | -100.0% |
| Q1 2017 | $563,000 | -92.3% | 170,091 | -94.4% | 0.00% | -85.7% |
| Q4 2016 | $7,273,000 | -44.4% | 3,056,027 | -14.2% | 0.01% | -46.2% |
| Q3 2016 | $13,078,000 | +427.8% | 3,563,359 | +220.7% | 0.01% | +333.3% |
| Q2 2016 | $2,478,000 | +1.7% | 1,111,111 | -5.2% | 0.00% | 0.0% |
| Q1 2016 | $2,437,000 | +565.8% | 1,171,479 | +870.4% | 0.00% | – |
| Q4 2015 | $366,000 | +33.6% | 120,717 | +8.9% | 0.00% | – |
| Q3 2015 | $274,000 | +128.3% | 110,847 | +197.4% | 0.00% | – |
| Q2 2015 | $120,000 | -66.3% | 37,274 | -62.7% | 0.00% | – |
| Q1 2015 | $356,000 | +978.8% | 99,910 | +482.2% | 0.00% | – |
| Q3 2014 | $33,000 | -87.0% | 17,161 | -75.4% | 0.00% | – |
| Q2 2014 | $253,000 | -25.6% | 69,771 | -20.4% | 0.00% | – |
| Q1 2014 | $340,000 | +1378.3% | 87,661 | +995.6% | 0.00% | – |
| Q4 2013 | $23,000 | -63.5% | 8,001 | -54.8% | 0.00% | – |
| Q3 2013 | $63,000 | -60.6% | 17,706 | -63.0% | 0.00% | – |
| Q2 2013 | $160,000 | – | 47,838 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |